COST Action CA18218

[Webinar] Burden of disease assessment for COVID-19: initial insights and future perspectives

Friday 21 May 2021, 14h-15h CET

About the webinar

As the COVID-19 pandemic continues to unroll, more and more countries are assessing the population health impact of COVID-19. The burden of disease approach offers a framework that allows for comprehensive and comparable population health impact assessments, making it possible to compare the impact of COVID-19 to that of other diseases and risk factors.

In this webinar, we will unveil some initial estimates of the burden of COVID-19 at population level. We will also zoom in on post COVID conditions, which constitute a significant, but to date highly uncertain, contribution to the overall COVID-19 disease burden.

This webinar is jointly organized by the unCoVer network and the European Burden of Disease Network.

Programme

14h00 Welcome & Introduction
— Prof Dr José Peñalvo, Institute of Tropical Medicine, Belgium
14h05 Disease burden of COVID-19 in Germany (with Q&A)
— Dr Elena von der Lippe, Robert Koch Institute, Germany
14h20 Disease burden of COVID-19 in Scotland (with Q&A)
— Mr Grant Wyper, Public Health Scotland, UK
14h35 Post COVID conditions: evolving immunological evidence and future perspectives (with Q&A)
— Dr Joe Breen, National Institute of Allergy and Infectious Diseases, USA
14h50 General discussion

Speakers

Elena von der Lippe
Elena von der Lippe

Dr Elena von der Lippe is a scientific researcher at the Robert Koch Institute (RKI) in Berlin, Germany. She studied statistics and obtained her PhD in Demography. She has been working in RKI since 2008 in the Department of Epidemiology and Health Monitoring. She has worked on the conception, organization, quality assessment and analysis of different epidemiological studies conducted at RKI. Since 2015 she is involved in Burden of Disease assessments and is the methodological leader of the Germany BURDEN2020 Project.

Grant Wyper
Grant Wyper

Mr Grant Wyper is a public health intelligence adviser at Public Health Scotland, UK, where he contributes towards the delivery of the Scottish Burden of Disease study. His background is in Statistics, and his interests are harnessing routine administrative data to monitor population-level health, and inequalities. He also has interests in the evaluation of policy interventions, designed to improve population health outcomes.

Joe Breen
Joe Breen

Dr. Breen is currently the Immunoregulation Section Chief in the Basic Immunology Branch in the Division of Allergy, Immunology and Transplantation (DAIT) at the National Institute of Allergy and Infectious Diseases (NIAID), NIH. Dr. Breen joined NIH in 2003 and assumed his current position in 2014. Dr. Breen serves on a variety of trans-NIH committees and frequently interacts with various internal and external stakeholders regarding DAIT and NIAID research priorities, including ME/CFS and COVID-19. Dr. Breen manages a portfolio containing computational immunology, immune profiling, and bioinformatics in the Basic Immunology Branch.

Registration

Click here to register for the webinar

Upon registration, you will receive a meeting invitation with the login details for the webinar.

About COST

COST (European Cooperation in Science and Technology – see www.cost.eu) is a unique platform where European researchers can jointly develop their ideas and initiatives across all scientific disciplines through trans-European networking of nationally funded research. COST is supported by the European Union (EU) Horizon 2020 Programme.

Get in touch

Cost

EU Flag

COST is supported by the EU Framework Programme Horizon 2020

Website by  woluweb mini